New Delhi, April 18 (IANS) Major drug maker Lupin on Saturday said that the US health regulator has issued a ‘Form 483’ with three observations to its manufacturing facility in Somerset, New Jersey, following a recent inspection.In a regulatory filing, the pharmaceutical company said that the inspection by the US Food and Drug Administration (USFDA) was conducted this week between April 13 and April 17.”The inspection was completed with the issuance of a Form 483 carrying three observations,” th…
Latest Good Manufacturing Practices News & Updates
Kasauli, Feb 21 (IANS) Union Minister for Health and Family Welfare J. P. Nadda on Saturday launched the indigenously manufactured tetanus and adult diphtheria (Td) vaccine at the Central Research Institute (CRI) here in Himachal Pradesh. Addressing the gathering, Union Minister Nadda congratulated the scientists, technical experts and staff of the Central Research Institute (CRI), Kasauli, describing the indigenous launch of the tetanus and adult diphtheria vaccine as a momentous and historic o…